Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease

Author: Rivas Christelle   Baaten Bas   Quéré Pascale   Djeraba Aouatef   Musset Eugène   van Rooijen Nico  

Publisher: Taylor & Francis Ltd

ISSN: 1465-3338

Source: Avian Pathology, Vol.32, Iss.2, 2003-04, pp. : 139-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content